IQT

Activity from announced rounds

Activity in this selectionOct 24, 2026 · Biotech · Jan 1, 2026
Rounds participated in
2
Confirmed lead rounds
—
2 roles undisclosed
New companies
2
First participation on record · 0 follow-on
Funding in participating rounds
$230M
1 disclosed · full round size, not this investor’s share

By stage

Seed1
Series C+1

By primary sector

Biotech1
Healthtech1

By country

Japan1
United States1

Rounds

2 in this selection
bitBiome

Discovers and engineers novel enzymes and microbial strains for bio-based products using AI

>$45MSeed+
Role not disclosed
Science Corporation

Develops brain-computer interface retinal implants to restore vision in patients with retinal diseases

$230MSeries C
Role not disclosed